Jan P Lerut
Overview
Explore the profile of Jan P Lerut including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
657
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lai Q, Lesari S, Lerut J
Curr Opin Organ Transplant
. 2022 Nov;
27(4):305-311.
PMID: 36354256
Purpose Of Review: Morphological criteria (i.e., Milan Criteria) have been considered for a long time to be the best tool for selecting patients with hepatocellular cancer (HCC) waiting for liver...
2.
Lerut J, Gondolesi G
Best Pract Res Clin Gastroenterol
. 2022 Aug;
58-59:101786.
PMID: 35988958
No abstract available.
3.
Lai Q, Viveiros A, Iesari S, Vitale A, Mennini G, Onali S, et al.
Front Oncol
. 2022 May;
12:877107.
PMID: 35574299
Background: Long-term survival after liver transplantation (LT) for hepatocellular cancer (HCC) continues to increase along with the modification of inclusion criteria. This study aimed at identifying risk factors for 5-...
4.
Lerut J, Gondolesi G
Best Pract Res Clin Gastroenterol
. 2021 Dec;
54-55:101767.
PMID: 34874848
Immunosuppression handling plays a key role in the early and long-term results of transplantation. The development of multiple immunosuppressive drugs led to numerous clincial trials searching to reach the ideal...
5.
Gigante E, Lai Q, Lerut J, Nault J
Dig Liver Dis
. 2020 Jun;
52(9):1039-1040.
PMID: 32553702
No abstract available.
6.
7.
8.
Lerut J, Lai Q, de Ville de Goyet J
Liver Transpl
. 2019 Sep;
26(1):92-99.
PMID: 31509649
Extended splanchnic venous thrombosis represents a challenge for the liver transplantation (LT) surgeon. In the absence of large venous tributaries, the cavoportal hemitransposition (CPHTr) and the combined liver-intestinal or multivisceral...
9.
10.
Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H, et al.
Gut
. 2018 Jul;
68(6):1014-1023.
PMID: 30045880
Objective: To characterise gut microbiome in patients with hepatocellular carcinoma (HCC) and evaluate the potential of microbiome as non-invasive biomarkers for HCC. Design: We collected 486 faecal samples from East...